机器人放射线治疗市场－全球产业规模、份额、趋势、机会及预测（按产品、技术、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球机器人放射治疗市场预计将从 2025 年的 20.4 亿美元成长到 2031 年的 38.2 亿美元，复合年增长率为 11.02%。

该领域利用采用机器人自动化技术的医疗系统，能够精准地输送放射线束，并即时追踪受影响区域的移动。推动该市场成长要素是全球癌症负担日益加重，以及对能够最大限度减少对周围器官毒性的非侵入性治疗的需求不断增长。此外，人口老化也促使人们寻求治疗方法。美国癌症协会在2024年预测，到2050年，全球每年新增癌症病例将达3,500万例，凸显了大幅扩充放射治疗能力的必要性。

市场推广的一大障碍是购买和安装设备所需的高额资本投入。这些成本往往超出发展中地区医疗机构的预算，导致采购仅限于都市区。这一经济障碍显着限制了市场渗透率，并加剧了经济状况各异的地区在获得先进癌症治疗方面的不平等。

市场驱动因素

即时影像处理和运动控制技术的进步是全球机器人放射治疗市场的关键驱动力，彻底改变了治疗的精确度和安全性。现代机器人系统整合了人工智慧演算法和连续影像引导功能，能够动态调整放射剂量，确保将高剂量辐射精准输送到靶区，同时最大限度地减少对正常组织的影响。这种能力正在推动大量的投资。例如，医疗器材网路（Medical Device Network）在2024年11月报道称，Zap Surgical Systems已成功资金筹措7,800万美元，用于加速其保险箱的放射线手术平台的全球扩张。此外，Accuray Incorporated在2024年8月宣布，其2024财年的总订单金额达到3.421亿美元，证实了市场对高精度机器人系统的强劲临床需求。

第二个关键驱动因素是医疗基础设施的扩张和政府投资的增加，这提高了新兴市场和成熟市场获得资本密集机器人解决方案的途径。各国政府日益重视肿瘤科的现代化改造，以缩短病患等待时间并提高存活率。例如，根据英国国家卫生执行局2024年10月发布的消息，英国政府宣布投资7,000万英镑，以最新技术升级老旧的放射治疗设备，以缩短等待时间。此类公共部门的努力对于克服经济障碍、使世界各地更多医疗机构能够提供先进的癌症治疗至关重要。

市场挑战

实施和安装机器人放射治疗系统所需的大量资本投入，对全球市场扩张构成了重大障碍。这些先进系统价格昂贵，往往超出医疗机构的预算，尤其是在开发中国家和农村地区。因此，采购通常仅限于资源充足的大规模大都会圈，导致广大地区无法获得精准癌症治疗。这种经济壁垒直接阻碍了市场渗透，妨碍了推动销售成长和规模经济所需的广泛应用。

成本限制的影响显而易见，全球设备分布极度不均，限制了潜在市场规模。核能（IAEA）2024年报告称，低收入国家平均每1,560万人仅拥有一台放射治疗设备，而高所得国家平均每13万人约有一台。这种巨大的设备差距凸显了高昂的资本投入如何有效地将很大一部分潜在全球基本客群拒之门外，阻碍了新兴市场机器人放射治疗市场的整体成长。

市场趋势

向低分割和立体定位治疗通讯协定的转变正在从根本上重塑市场格局，它将治疗压缩到更少次数、更高剂量的疗程中，即所谓的「立体定位体部放射治疗（SBRT）」。这种转变在保持治疗效果的同时，最大限度地提高了设备吞吐量和患者便利性，从而在现有设施无需立即扩充硬体的情况下，显着提升了治疗能力。近期的数据也反映了这种转变的规模：根据 Medscape Medical News 2024 年 12 月对超过一百万份患者记录的分析，64% 的浸润性乳癌患者接受了低分割放射治疗，这有力地支持了向这些加速治疗标准的明确转变。

同时，磁振造影引导机器人加速器的广泛应用正在革新软组织标靶治疗，它能够在放射治疗过程中提供肿瘤的高解析度视觉化影像。与传统的X光引导不同，这些混合系统使临床医生能够即时观察解剖结构的变化，从而实现更严格的安全边界，保护重要结构并最大限度地减少副作用。 Elekta公司在2025年5月举行的欧洲放射肿瘤学会（ESTRO）年会上发表的ERECT试验结果证实了该技术的良好毒性特征。研究发现，接受Unity MR-Linac治疗的男性患者6个月内勃起功能障碍发生率仅6%，而接受传统放射治疗的患者比例为21%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球机器人放射线治疗市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（放射治疗系统、软体、3D相机（表面导引）、其他）
  • 依技术分类（直线加速器、传统直线加速器、MRI直线加速器、立体定位放射治疗系统、电脑刀、伽玛刀、粒子治疗、质子治疗、重离子治疗）
  • 依应用领域（前列腺癌、乳癌、肺癌、头颈癌、结肠癌、其他癌症）
  • 依最终使用者（医院、独立放射治疗中心）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美机器人放射线治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲机器人放射线治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区机器人放射线治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲机器人放射线治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美机器人放射线治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球机器人放射线治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Accuray
• Varian
• Elekta
• ViewRay
• IBA
• Hitachi
• Mevion Medical Systems
• RaySearch Laboratories
• Siemens Healthineers
• Alphatec

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Robotic Radiotherapy Market is projected to expand from USD 2.04 Billion in 2025 to USD 3.82 Billion by 2031, registering a CAGR of 11.02%. This sector involves medical systems that use robotic automation to deliver focused radiation beams with high precision and real-time motion tracking. The market is primarily driven by the rising global burden of cancer and a growing preference for noninvasive procedures that minimize toxicity to surrounding organs. Furthermore, the aging population is fueling demand for treatments that provide greater patient comfort and shorter durations. In '2024', the 'American Cancer Society' estimated that annual global cancer diagnoses will reach 35 million by 2050, highlighting the need for substantial radiotherapy capacity expansion.

A significant barrier to widespread market adoption is the high capital expenditure required for equipment acquisition and installation. These costs often exceed the budgets of healthcare facilities in developing regions, restricting procurement to major metropolitan centers. This financial hurdle severely limits market penetration and worsens the inequality in access to advanced cancer care across different economic geographies.

Market Driver

Technological advancements in real-time imaging and motion management are a primary catalyst for the Global Robotic Radiotherapy Market, revolutionizing treatment precision and safety. Modern robotic systems integrate AI algorithms with continuous image guidance to dynamically adjust radiation delivery, ensuring high doses reach the target while sparing healthy tissue. This capability has spurred significant investment; for example, Medical Device Network reported in November 2024 that Zap Surgical Systems secured $78 million to accelerate the global distribution of its vault-free gyroscopic radiosurgery platform. Additionally, Accuray Incorporated reported gross orders of $342.1 million for fiscal year 2024 in August 2024, underscoring the strong clinical demand for high-precision robotic systems.

The second key driver is the expansion of healthcare infrastructure and government funding, which improves access to capital-intensive robotic solutions in both emerging and established markets. Governments are increasingly prioritizing the modernization of oncology departments to address patient backlogs and improve survival rates. For instance, according to National Health Executive in October 2024, the UK government announced a £70 million investment to replace outdated radiotherapy machines with modern technology to reduce waiting lists. Such public sector initiatives are vital for overcoming financial barriers and ensuring advanced cancer care is available across a broader range of global facilities.

Market Challenge

The substantial capital expenditure needed to acquire and install robotic radiotherapy systems creates a major obstacle to the broader expansion of the global market. These advanced systems carry high price tags that frequently exceed the financial resources of healthcare institutions, particularly in developing economies and rural areas. As a result, procurement is often limited to well-funded metropolitan centers, leaving large geographic regions with insufficient access to precision cancer treatments. This financial barrier directly hampers market penetration by preventing the widespread adoption necessary to drive volume growth and economies of scale.

The impact of this cost constraint is evident in the severe global disparity in equipment distribution, which limits the addressable market. In '2024', the 'International Atomic Energy Agency' reported that low-income countries possess only one radiotherapy machine for every 15.6 million people, compared to one machine for approximately 130,000 individuals in high-income nations. This significant equipment gap underscores how high capital requirements effectively exclude a large portion of the potential global customer base, stalling the overall growth trajectory of the robotic radiotherapy market in emerging sectors.

Market Trends

The shift toward hypofractionated and stereotactic treatment protocols is fundamentally restructuring the market by condensing therapy into fewer, higher-dose sessions known as stereotactic body radiation therapy (SBRT). This transition maximizes machine throughput and patient convenience while maintaining therapeutic efficacy, effectively increasing the capacity of existing centers without requiring immediate hardware expansion. The scale of this adoption is reflected in recent data; according to Medscape Medical News in December 2024, an analysis of over one million patient records showed that 64% of patients with invasive breast cancer received hypofractionated radiation, validating the decisive move toward these accelerated standards.

Simultaneously, the proliferation of MRI-guided robotic linear accelerators is revolutionizing soft-tissue targeting by enabling high-definition visualization of tumors during radiation delivery. Unlike standard X-ray guidance, these hybrid systems allow clinicians to observe anatomical changes in real-time and reduce safety margins, thereby sparing critical structures and minimizing side effects. The superior toxicity profile of this technology was confirmed when, according to Elekta in May 2025, results from the ERECT trial presented at the ESTRO annual congress showed that men treated with the Unity MR-Linac had a six-month erectile dysfunction rate of only 6%, compared to 21% for those undergoing conventional radiotherapy.

Key Market Players

• Accuray
• Varian
• Elekta
• ViewRay
• IBA
• Hitachi
• Mevion Medical Systems
• RaySearch Laboratories
• Siemens Healthineers
• Alphatec

Report Scope

In this report, the Global Robotic Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Robotic Radiotherapy Market, By Product

• Radiotherapy Systems
• Software
• 3D Cameras (Surface Guided)
• Others

Robotic Radiotherapy Market, By Technology

• Linear Accelerators
• Conventional Linear Accelerators
• MRI - Linear Accelerators
• Stereotactic Radiation Therapy Systems
• Cyberknife
• Gamma Knife
• Particle Therapy
• Proton Beam Therapy
• Heavy Ion beam Therapy

Robotic Radiotherapy Market, By Application

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head & Neck Cancer
• Colorectal Cancer
• Other

Robotic Radiotherapy Market, By End User

• Hospitals
• Independent Radiotherapy Centers

Robotic Radiotherapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Robotic Radiotherapy Market.

Available Customizations:

Global Robotic Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Robotic Radiotherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided), Others)
  • 5.2.2. By Technology (Linear Accelerators, Conventional Linear Accelerators, MRI - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy, Heavy Ion beam Therapy)
  • 5.2.3. By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Other)
  • 5.2.4. By End User (Hospitals, Independent Radiotherapy Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Robotic Radiotherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Robotic Radiotherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Robotic Radiotherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Robotic Radiotherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Robotic Radiotherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Robotic Radiotherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Robotic Radiotherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Robotic Radiotherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Robotic Radiotherapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Robotic Radiotherapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Robotic Radiotherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Robotic Radiotherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Robotic Radiotherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Robotic Radiotherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Robotic Radiotherapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Robotic Radiotherapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Robotic Radiotherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Robotic Radiotherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Robotic Radiotherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Robotic Radiotherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Robotic Radiotherapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Robotic Radiotherapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Robotic Radiotherapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Robotic Radiotherapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Robotic Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Accuray
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Varian
• 15.3. Elekta
• 15.4. ViewRay
• 15.5. IBA
• 15.6. Hitachi
• 15.7. Mevion Medical Systems
• 15.8. RaySearch Laboratories
• 15.9. Siemens Healthineers
• 15.10. Alphatec

16. Strategic Recommendations

17. About Us & Disclaimer